Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?

Martin AM, Kanetsky PA, Amirimani B, Colligon TA, Athanasiadis G, Shih HA, Gerrero MR, Calzone K, Rebbeck TR, Weber BL.

J Med Genet. 2003 Apr;40(4):e34. No abstract available.

2.

Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.

Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, Van Belle P, Elder DE, Herlyn M.

Cancer Res. 2003 Feb 15;63(4):756-9.

3.

Recent advances in breast cancer biology.

Gerrero MR, Weber BL.

Curr Opin Oncol. 2001 Nov;13(6):415-9. Review.

PMID:
11673679
4.

Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors.

Li P, He X, Gerrero MR, Mok M, Aggarwal A, Rosenfeld MG.

Genes Dev. 1993 Dec;7(12B):2483-96.

5.

Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs.

Gerrero MR, McEvilly RJ, Turner E, Lin CR, O'Connell S, Jenne KJ, Hobbs MV, Rosenfeld MG.

Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10841-5.

6.

Delayed nerve regeneration in streptozotocin diabetic rats.

Longo FM, Powell HC, Lebeau J, Gerrero MR, Heckman H, Myers RR.

Muscle Nerve. 1986 Jun;9(5):385-93.

PMID:
2941683

Supplemental Content

Loading ...
Support Center